Back to GLENMEDE TRUST CO NA GLENMEDE TRUST CO NA

RETARETA
11 quarters

Position history for GLENMEDE TRUST CO NAGLENMEDE TRUST CO NA's holdings in REATA PHARMACEUTICALS INC

GLENMEDE TRUST CO NA previously held 0 shares of RETA (REATA PHARMACEUTICALS INC), worth $0 as of 2023-Q3.

Final Value

$0

Final Shares

0

Total Value Change

-$39,000

Total Shares Change

-460

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2023-Q3
Latest
Exited
0
-100.0%
$00.0%
0
2023-Q2
Unchanged
6,502
0.0%
$591,1610.0%
0
2023-Q1
New
6,502
-
$591,1610.0%
34
2020-Q4
Exited
0
-100.0%
$00.0%
0
2020-Q3
Decreased
400
-62.3%
$38,0000.0%
0
2020-Q2
Decreased
1,062
-38.8%
$165,0000.0%
0
2020-Q1
Unchanged
1,735
0.0%
$354,0000.0%
0
2019-Q4
Increased
1,735
+269.9%
$354,0000.0%
38
2019-Q3
Increased
469
+2.0%
$37,0000.0%
20
2019-Q2
Unchanged
460
0.0%
$43,0000.0%
0
2019-Q1
New
460
-
$39,0000.0%
28

Other major holders of RETA: BNP PARIBAS FINANCIAL MARKETS, Invesco Ltd., FRANKLIN RESOURCES INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used